GRASPING TIRZEPATIDE AND MOUNJARO: THE THOROUGH EXPLANATION

Both Semaglutide and the drug represent new strategies to treating type 2 diabetes, and increasingly, obesity. Tirzepatide is a dual receptor activator that works on multiple hormones involved in glucose regulation: this peptide and another incretin. It, often viewed as a trade name for Semagluti